Meeting
2019 Genitourinary Cancers Symposium
P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).
Authors
Alison Yan Zhang
NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia
Alison Yan Zhang , Guy C. Toner , Nicola Jane Lawrence , Martin R. Stockler , Andrew James Martin , Kate Ford , Amanda Gwendolyn Stevanovic , David Wyld , Euan Thomas Walpole , Simon Troon , Fritha J. Hanning , Girish Mallesara , Andrew James Weickhardt , Alison Jane Birtle , Ian D. Davis , Peter S. Grimison
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers
Sub Track
Testicular Cancer
Clinical Trial Registration Number
NCT02582697
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr TPS539)
DOI
10.1200/JCO.2019.37.7_suppl.TPS539
Abstract #
TPS539
Poster Bd #
N16
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours (GCTs).
First Author: Peter S. Grimison
Poster
2018 Genitourinary Cancers Symposium
P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).
First Author: Namrata Nayar
Poster
2017 ASCO Annual Meeting
P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours (GCTs).
First Author: Peter S. Grimison
Poster
2020 Genitourinary Cancers Symposium
P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).
First Author: Shalini Subramaniam